Dow Jones

38,686.32

1.51%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Sigyn Therapeutics Inc (QB) (SIGY)
Sigyn Therapeutics Inc (QB) (SIGY) Noticias

SIGY

Sigyn Therapeutics (QB) (SIGY)

Sigyn Therapeutics Inc (QB)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:SIGY

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
31/01/2024	15:20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
14/08/2023	14:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
08/06/2023	13:38	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
17/05/2023	06:15	InvestorsHub NewsWire	Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark Application	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
15/05/2023	16:35	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
10/05/2023	16:27	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
31/03/2023	09:06	InvestorsHub NewsWire	Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
31/03/2023	05:19	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
14/09/2022	11:37	InvestorsHub NewsWire	Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
03/08/2022	06:07	InvestorsHub NewsWire	Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
23/06/2022	05:02	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
23/05/2022	04:00	TipRanks	Analysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
04/02/2022	09:48	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
17/12/2021	07:48	InvestorsHub NewsWire	Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or Vaccines	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
26/10/2021	09:43	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
10/08/2021	06:18	InvestorsHub NewsWire	Sigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
29/07/2021	09:19	InvestorsHub NewsWire	Sigyn Therapeutics Announces Successful Completion of Animal Pilot Study	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
15/07/2021	07:00	InvestorsHub NewsWire	Sigyn Therapeutics Announces Rapid Elimination of Hepatic Toxins from Human Blood Plasma	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
28/06/2021	08:48	InvestorsHub NewsWire	The Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
31/03/2021	11:49	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:SIGY	Sigyn Therapeutics Inc (QB)
02/11/2020	07:41	InvestorsHub NewsWire	Sigyn Therapeutics (SIGY) CEO Note: Rethinking the Treatment of Sepsis and Other Life-Threatening Inflammatory Conditions	USOTC:SIGY	Sigyn Therapeutics Inc (QB)